Casi de Young
Corporate Officer/Principal bei SHATTUCK LABS, INC.
Vermögen: 875 202 $ am 30.04.2024
Profil
Casi de Young is currently the Chief Business Officer at Shattuck Labs, Inc. She previously worked as the Operations Director-Oncology at Merck KGaA, EMD Pharmaceuticals, Inc., and ODC Therapy, Inc. She was also a Consulting Manager at Accenture Ltd.
and Vice President-Business Development at Reata Pharmaceuticals, Inc. and Mirna Therapeutics, Inc. Ms. de Young received her undergraduate degree from Southwestern University and her MBA from McCombs School of Business.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
SHATTUCK LABS, INC.
0,19% | 30.01.2024 | 89 489 ( 0,19% ) | 875 202 $ | 30.04.2024 |
Aktive Positionen von Casi de Young
Unternehmen | Position | Beginn |
---|---|---|
SHATTUCK LABS, INC. | Corporate Officer/Principal | 01.12.2019 |
Ehemalige bekannte Positionen von Casi de Young
Unternehmen | Position | Ende |
---|---|---|
ImmuneSensor Therapeutics, Inc.
ImmuneSensor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services ImmuneSensor Therapeutics, Inc. is a clinical-stage biotechnology company based in Dallas, TX. ImmuneSensor Therapeutics is building a pipeline of novel small molecule and adc immune stimulating candidates that aim to modulate the innate immune system. The company is led by a team of experienced biotech professionals who are committed to creating novel treatments that harness the body’s innate immune system to treat a wide range of diseases. ImmuneSensor Therapeutics is focused on discovering and developing novel therapies that leverage the incredible versatility and therapeutic potential of the cgas-sting pathway, which is one of the key pathways in the innate immunity system that works to detect both foreign and host-derived DNA. The company was founded in 2014 by Zhijian Chen and Jet Li, and the CEO is Ernest Wong. | Geschäftsführer | 01.12.2019 |
Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX. | Public Communications Contact | 01.06.2017 |
REATA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.12.2013 |
ODC Therapy, Inc.
ODC Therapy, Inc. Medical/Nursing ServicesHealth Services ODC Therapy, Inc. operates offices of physical, occupational and speech therapists and audiologists. The company develops, produces and distributes customized cancer vaccines to individual patients and then monitors their immune response after treatment. The company was founded in 2004 and is headquartered in Dallas, TX. | Corporate Officer/Principal | 01.03.2008 |
EMD Pharmaceuticals, Inc.
EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski. | Corporate Officer/Principal | 01.01.2005 |
Ausbildung von Casi de Young
Southwestern University | Undergraduate Degree |
McCombs School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
SHATTUCK LABS, INC. | Health Technology |
MERCK KGAA | Health Technology |
Private Unternehmen | 6 |
---|---|
ODC Therapy, Inc.
ODC Therapy, Inc. Medical/Nursing ServicesHealth Services ODC Therapy, Inc. operates offices of physical, occupational and speech therapists and audiologists. The company develops, produces and distributes customized cancer vaccines to individual patients and then monitors their immune response after treatment. The company was founded in 2004 and is headquartered in Dallas, TX. | Health Services |
Accenture Ltd.
Accenture Ltd. Miscellaneous Commercial ServicesCommercial Services Accenture Ltd. provides services to management consulting, technology services and outsourcing organizations. It provides management consulting, technology, systems integration and outsourcing services and solutions to the communications, electronics, high technology, media and entertainment industries. The company was founded in 1984 and is headquartered in Hamilton, Bermuda. | Commercial Services |
Reata Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
EMD Pharmaceuticals, Inc.
EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski. | Health Technology |
Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX. | Commercial Services |
ImmuneSensor Therapeutics, Inc.
ImmuneSensor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services ImmuneSensor Therapeutics, Inc. is a clinical-stage biotechnology company based in Dallas, TX. ImmuneSensor Therapeutics is building a pipeline of novel small molecule and adc immune stimulating candidates that aim to modulate the innate immune system. The company is led by a team of experienced biotech professionals who are committed to creating novel treatments that harness the body’s innate immune system to treat a wide range of diseases. ImmuneSensor Therapeutics is focused on discovering and developing novel therapies that leverage the incredible versatility and therapeutic potential of the cgas-sting pathway, which is one of the key pathways in the innate immunity system that works to detect both foreign and host-derived DNA. The company was founded in 2014 by Zhijian Chen and Jet Li, and the CEO is Ernest Wong. | Commercial Services |